A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 2 September 2020) has been published and includes articles on: 5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity Flucytosine (Ancotil): new contraindication in patients with DPD deficiency Niraparib...
In response to significant ongoing disruption to the supply of Fluoxetine 30mg capsules and Salazopyrin® EN-Tabs 500mg, two Serious Shortage Protocols (SSPs) have been been issued by the Department of Health and Social Care (DHSC). Introduced with immediate effect today, Tuesday 20th October 2020, SSP07 has been developed by clinicians and provides pharmacists with procedures to...
In July 2020 (the most recently priced dispensing month), a total of 490 items issued via Electronic Prescription Service (EPS) were returned as disallowed by the NHS Business Services Authority (NHSBSA). The NHSBSA has shared with PSNC a list (see table below) of the top 10 disallowed prescription items submitted for payment via EPS in...
Class 2 MHRA Medicines Recall: Epilim 500mg Gastro-Resistant Tablets (Sanofi) Drug alert number: EL (20) A/48 Date issued: 14 October 2020 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Epilim 500mg Gastro-Resistant Tablets (Sanofi) PL 04425/0303 Sanofi has informed the MHRA that it is recalling the below...
The Department of Health and Social Care (DHSC) has re-determined the September 2020 concessionary price for Tolterodine 1mg tablets (56) as £12.90. All prescriptions for Tolterodine 1mg tablets submitted to NHS Business Services Authority (NHSBSA) for payment for the dispensing month of September will be reimbursed at this new price. The final price concession update for September 2020 was published by DHSC...
Recent Comments